A BLIND CONTROLLED TRIAL OF DEXTRAN 40 IN THE TREATMENT OF ISCHÆMIC STROKE
A blind controlled trial of dextran 40 in ischaemic stroke is reported. In the treated group mortality in the acute stage in patients with severe strokes was significantly reduc...